Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 9 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 11 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2026 Filed Jun 1, 2026 20:05 UTC |
Townson SharonChief Scientific Officer
|
Exercise / conversionCommon Stock | 6,000 | $6.14 | $36,840.00 |
DisclosureSEC source: 0001193125-26-251395 · ownership.xml · nonDerivative · entry 1 Townson Sharon · CIK 0001855689 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. Read SEC document |
| May 27, 2026 Filed May 28, 2026 23:10 UTC |
Champoux JenniferChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,175 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001193125-26-245728 · ownership.xml · derivative · entry 3 Champoux Jennifer · CIK 0002025233 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,649 Underlying: Common Stock · 2,175 shares Expires 2034-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2026. F2 · derivative.exercise_date: 25% of this option vested on May 28, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| May 27, 2026 Filed May 28, 2026 23:10 UTC |
Champoux JenniferChief Operating Officer
|
SaleCommon Stock | 2,175 | $20.00 | $43,500.00 |
DisclosureSEC source: 0001193125-26-245728 · ownership.xml · nonDerivative · entry 2 Champoux Jennifer · CIK 0002025233 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,371 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2026. Read SEC document |
| May 27, 2026 Filed May 28, 2026 23:10 UTC |
Champoux JenniferChief Operating Officer
|
Exercise / conversionCommon Stock | 2,175 | $3.98 | $8,656.50 |
DisclosureSEC source: 0001193125-26-245728 · ownership.xml · nonDerivative · entry 1 Champoux Jennifer · CIK 0002025233 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2026. Read SEC document |
| May 22, 2026 Filed May 26, 2026 20:05 UTC |
Champoux JenniferChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,176 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001193125-26-239240 · ownership.xml · derivative · entry 3 Champoux Jennifer · CIK 0002025233 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,824 Underlying: Common Stock · 2,176 shares Expires 2034-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2026. F2 · derivative.exercise_date: 25% of this option vested on May 28, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| May 22, 2026 Filed May 26, 2026 20:05 UTC |
Champoux JenniferChief Operating Officer
|
SaleCommon Stock | 2,176 | $19.00 | $41,344.00 |
DisclosureSEC source: 0001193125-26-239240 · ownership.xml · nonDerivative · entry 2 Champoux Jennifer · CIK 0002025233 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,371 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2026. Read SEC document |
| May 22, 2026 Filed May 26, 2026 20:05 UTC |
Champoux JenniferChief Operating Officer
|
Exercise / conversionCommon Stock | 2,176 | $3.98 | $8,660.48 |
DisclosureSEC source: 0001193125-26-239240 · ownership.xml · nonDerivative · entry 1 Champoux Jennifer · CIK 0002025233 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2026. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:05 UTC |
Manning Anthony M.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0001193125-26-236840 · ownership.xml · derivative · entry 3 Manning Anthony M. · CIK 0001716468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,100 Underlying: Common Stock · 10,000 shares Expires 2034-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:05 UTC |
Manning Anthony M.Director
|
SaleCommon Stock | 10,000 | $18.01 | $180,100.00 |
DisclosureSEC source: 0001193125-26-236840 · ownership.xml · nonDerivative · entry 2 Manning Anthony M. · CIK 0001716468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:05 UTC |
Manning Anthony M.Director
|
Exercise / conversionCommon Stock | 10,000 | $4.16 | $41,600.00 |
DisclosureSEC source: 0001193125-26-236840 · ownership.xml · nonDerivative · entry 1 Manning Anthony M. · CIK 0001716468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:05 UTC |
Warmuth MarkusDirector · President & CEO
|
SaleCommon Stock | 5,467 | $18.92 | $103,446.57 |
DisclosureSEC source: 0001193125-26-206344 · ownership.xml · nonDerivative · entry 1 Warmuth Markus · CIK 0001855643 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 600,004 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.67 to $19.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:05 UTC |
Warmuth MarkusDirector · President & CEO
|
SaleCommon Stock | 8,000 | $17.64 | $141,124.80 |
DisclosureSEC source: 0001193125-26-156981 · ownership.xml · nonDerivative · entry 1 Warmuth Markus · CIK 0001855643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 605,471 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.64 to $17.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 09, 2026 Filed Apr 10, 2026 20:07 UTC |
Nickson PhilipChief Business & Legal Officer
|
SaleCommon Stock | 5,845 | $17.69 | $103,412.66 |
DisclosureSEC source: 0001193125-26-151254 · ownership.xml · nonDerivative · entry 1 Nickson Philip · CIK 0001911369 · Chief Business & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.6901 to $17.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 06, 2026 Filed Apr 7, 2026 20:10 UTC |
Bowen MatthewPrincipal Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $16.93 | $0.00 |
DisclosureSEC source: 0001193125-26-145545 · ownership.xml · derivative · entry 2 Bowen Matthew · CIK 0002115025 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 19,500 shares Expires 2036-04-05 F2 · derivative.exercise_date: 25% of this option shall vest and become exercisable on April 6, 2027, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| April 06, 2026 Filed Apr 7, 2026 20:10 UTC |
Bowen MatthewPrincipal Accounting Officer
|
GrantCommon Stock | 4,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-145545 · ownership.xml · nonDerivative · entry 1 Bowen Matthew · CIK 0002115025 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,904 F1 · price: Represents restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of the RSUs shall vest on April 6, 2027, with the remainder vesting in 3 equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 22:24 UTC |
Dunn EdmundPrincipal Accounting Officer
|
SaleCommon Stock | 139 | $17.96 | $2,496.44 |
DisclosureSEC source: 0001193125-26-094296 · ownership.xml · nonDerivative · entry 1 Dunn Edmund · CIK 0001989401 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,554 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. Read SEC document |
| March 02, 2026 Filed Mar 2, 2026 22:02 UTC |
Dunn EdmundPrincipal Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 536 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0001193125-26-085677 · ownership.xml · derivative · entry 6 Dunn Edmund · CIK 0001989401 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 536 shares Expires 2032-02-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 02, 2026 Filed Mar 2, 2026 22:02 UTC |
Dunn EdmundPrincipal Accounting Officer
|
SaleCommon Stock | 536 | $17.50 | $9,380.00 |
DisclosureSEC source: 0001193125-26-085677 · ownership.xml · nonDerivative · entry 4 Dunn Edmund · CIK 0001989401 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,693 Read SEC document |
| March 02, 2026 Filed Mar 2, 2026 22:02 UTC |
Dunn EdmundPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 536 | $13.41 | $7,187.76 |
DisclosureSEC source: 0001193125-26-085677 · ownership.xml · nonDerivative · entry 3 Dunn Edmund · CIK 0001989401 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:50 UTC |
Warmuth MarkusDirector · President & CEO
|
SaleCommon Stock | 5,466 | $17.92 | $97,974.22 |
DisclosureSEC source: 0001193125-26-091733 · ownership.xml · nonDerivative · entry 1 Warmuth Markus · CIK 0001855643 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 613,471 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.50 to $18.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 22:02 UTC |
Dunn EdmundPrincipal Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,164 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0001193125-26-085677 · ownership.xml · derivative · entry 5 Dunn Edmund · CIK 0001989401 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 536 Underlying: Common Stock · 25,164 shares Expires 2032-02-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 22:02 UTC |
Dunn EdmundPrincipal Accounting Officer
|
SaleCommon Stock | 25,164 | $18.10 | $455,506.15 |
DisclosureSEC source: 0001193125-26-085677 · ownership.xml · nonDerivative · entry 2 Dunn Edmund · CIK 0001989401 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,693 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.06 to $18.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 22:02 UTC |
Dunn EdmundPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 25,164 | $13.41 | $337,449.24 |
DisclosureSEC source: 0001193125-26-085677 · ownership.xml · nonDerivative · entry 1 Dunn Edmund · CIK 0001989401 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:05 UTC |
Janku FilipChief Medical Officer
|
SaleCommon Stock | 9,189 | $19.50 | $179,160.69 |
DisclosureSEC source: 0001193125-26-066955 · ownership.xml · nonDerivative · entry 1 Janku Filip · CIK 0001862930 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,837 Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:05 UTC |
Warmuth MarkusDirector · President & CEO
|
SaleCommon Stock | 309 | $24.57 | $7,593.24 |
DisclosureSEC source: 0001193125-26-008902 · ownership.xml · nonDerivative · entry 3 Warmuth Markus · CIK 0001855643 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 618,937 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.43 to $24.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:05 UTC |
Warmuth MarkusDirector · President & CEO
|
SaleCommon Stock | 1,450 | $23.88 | $34,620.49 |
DisclosureSEC source: 0001193125-26-008902 · ownership.xml · nonDerivative · entry 2 Warmuth Markus · CIK 0001855643 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 619,246 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.43 to $24.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:05 UTC |
Warmuth MarkusDirector · President & CEO
|
SaleCommon Stock | 3,707 | $23.24 | $86,158.84 |
DisclosureSEC source: 0001193125-26-008902 · ownership.xml · nonDerivative · entry 1 Warmuth Markus · CIK 0001855643 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 620,696 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.42 to $23.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 05, 2026 Filed Jan 5, 2026 21:05 UTC |
Champoux JenniferChief Operating Officer
|
SaleCommon Stock | 2,629 | $15.17 | $39,881.93 |
DisclosureSEC source: 0001193125-26-002401 · ownership.xml · nonDerivative · entry 2 Champoux Jennifer · CIK 0002025233 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,371 F2 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.17 to $15.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 05, 2026 Filed Jan 5, 2026 21:04 UTC |
Dunn EdmundPrincipal Accounting Officer
|
SaleCommon Stock | 1,039 | $15.17 | $15,761.63 |
DisclosureSEC source: 0001193125-26-002390 · ownership.xml · nonDerivative · entry 1 Dunn Edmund · CIK 0001989401 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,693 F1 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.17 to $15.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 05, 2026 Filed Jan 5, 2026 21:04 UTC |
Janku FilipChief Medical Officer
|
SaleCommon Stock | 3,155 | $15.17 | $47,861.35 |
DisclosureSEC source: 0001193125-26-002386 · ownership.xml · nonDerivative · entry 2 Janku Filip · CIK 0001862930 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,026 F3 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.17 to $15.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 05, 2026 Filed Jan 5, 2026 21:04 UTC |
Warmuth MarkusDirector · President & CEO
|
SaleCommon Stock | 10,135 | $15.17 | $153,747.95 |
DisclosureSEC source: 0001193125-26-002389 · ownership.xml · nonDerivative · entry 2 Warmuth Markus · CIK 0001855643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 624,403 F2 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.17 to $15.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 05, 2026 Filed Jan 5, 2026 21:04 UTC |
Townson SharonChief Scientific Officer
|
SaleCommon Stock | 3,155 | $15.17 | $47,861.35 |
DisclosureSEC source: 0001193125-26-002385 · ownership.xml · nonDerivative · entry 2 Townson Sharon · CIK 0001855689 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,845 F2 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.17 to $15.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 05, 2026 Filed Jan 5, 2026 21:06 UTC |
Nickson PhilipChief Business & Legal Officer
|
SaleCommon Stock | 3,155 | $15.17 | $47,861.35 |
DisclosureSEC source: 0001193125-26-002406 · ownership.xml · nonDerivative · entry 2 Nickson Philip · CIK 0001911369 · Chief Business & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,845 F2 · kind: Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.17 to $15.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:05 UTC |
Champoux JenniferChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 158,000 | $0.00 Strike: $15.31 | $0.00 |
DisclosureSEC source: 0001193125-26-002401 · ownership.xml · derivative · entry 3 Champoux Jennifer · CIK 0002025233 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,000 Underlying: Common Stock · 158,000 shares Expires 2036-01-01 F4 · derivative.exercise_date: 25% of this option shall vest and become exercisable on January 2, 2027, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:05 UTC |
Champoux JenniferChief Operating Officer
|
GrantCommon Stock | 35,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-002401 · ownership.xml · nonDerivative · entry 1 Champoux Jennifer · CIK 0002025233 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 F1 · price: Represents restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of the RSUs shall vest on January 2, 2027, with the remainder vesting in 3 equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:04 UTC |
Janku FilipChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 139,000 | $0.00 Strike: $15.31 | $0.00 |
DisclosureSEC source: 0001193125-26-002386 · ownership.xml · derivative · entry 3 Janku Filip · CIK 0001862930 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,000 Underlying: Common Stock · 139,000 shares Expires 2036-01-01 F5 · derivative.exercise_date: 25% of this option shall vest and become exercisable on January 2, 2027, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:04 UTC |
Janku FilipChief Medical Officer
|
GrantCommon Stock | 31,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-002386 · ownership.xml · nonDerivative · entry 1 Janku Filip · CIK 0001862930 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,181 F1 · price: Represents restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of the RSUs shall vest on January 2, 2027, with the remainder vesting in 3 equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date. F2 · balance_after: Includes 1,992 shares acquired under the Issuer's 2021 Employee Stock Purchase Program on December 31, 2025. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:04 UTC |
Warmuth MarkusDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 406,000 | $0.00 Strike: $15.31 | $0.00 |
DisclosureSEC source: 0001193125-26-002389 · ownership.xml · derivative · entry 3 Warmuth Markus · CIK 0001855643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,000 Underlying: Common Stock · 406,000 shares Expires 2036-01-01 F4 · derivative.exercise_date: 25% of this option shall vest and become exercisable on January 2, 2027, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:04 UTC |
Warmuth MarkusDirector · President & CEO
|
GrantCommon Stock | 90,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-002389 · ownership.xml · nonDerivative · entry 1 Warmuth Markus · CIK 0001855643 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 634,538 F1 · price: Represents restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of the RSUs shall vest on January 2, 2027, with the remainder vesting in 3 equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:04 UTC |
Townson SharonChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 158,000 | $0.00 Strike: $15.31 | $0.00 |
DisclosureSEC source: 0001193125-26-002385 · ownership.xml · derivative · entry 3 Townson Sharon · CIK 0001855689 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,000 Underlying: Common Stock · 158,000 shares Expires 2036-01-01 F4 · derivative.exercise_date: 25% of this option shall vest and become exercisable on January 2, 2027, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:04 UTC |
Townson SharonChief Scientific Officer
|
GrantCommon Stock | 35,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-002385 · ownership.xml · nonDerivative · entry 1 Townson Sharon · CIK 0001855689 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,000 F1 · price: Represents restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of the RSUs shall vest on January 2, 2027, with the remainder vesting in 3 equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:06 UTC |
Nickson PhilipChief Business & Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 126,000 | $0.00 Strike: $15.31 | $0.00 |
DisclosureSEC source: 0001193125-26-002406 · ownership.xml · derivative · entry 3 Nickson Philip · CIK 0001911369 · Chief Business & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2036-01-01 F4 · derivative.exercise_date: 25% of this option shall vest and become exercisable on January 2, 2027, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:06 UTC |
Nickson PhilipChief Business & Legal Officer
|
GrantCommon Stock | 28,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-002406 · ownership.xml · nonDerivative · entry 1 Nickson Philip · CIK 0001911369 · Chief Business & Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,000 F1 · price: Represents restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of the RSUs shall vest on January 2, 2027, with the remainder vesting in 3 equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 16:05 UTC |
SCHIFF ANDREW NDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,700 | $0.00 Strike: $4.91 | $0.00 |
DisclosureSEC source: 0000950170-25-086699 · ownership.xml · derivative · entry 1 SCHIFF ANDREW N · CIK 0001172252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,700 Underlying: Common Stock · 30,700 shares Expires 2035-06-13 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:05 UTC |
Hughes Eric ADirector
|
GrantStock Option (Right to Buy) · Derivative | 30,700 | $0.00 Strike: $4.91 | $0.00 |
DisclosureSEC source: 0000950170-25-086704 · ownership.xml · derivative · entry 1 Hughes Eric A · CIK 0001938678 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,700 Underlying: Common Stock · 30,700 shares Expires 2035-06-13 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 16:05 UTC |
Blackwell KimberlyDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,700 | $0.00 Strike: $4.91 | $0.00 |
DisclosureSEC source: 0000950170-25-086702 · ownership.xml · derivative · entry 1 Blackwell Kimberly · CIK 0001816465 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,700 Underlying: Common Stock · 30,700 shares Expires 2035-06-13 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:10 UTC |
Behbahani AliDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 30,700 | $0.00 Strike: $4.91 | $0.00 |
DisclosureSEC source: 0000950170-25-086727 · ownership.xml · derivative · entry 1 Behbahani Ali · CIK 0001613867 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,700 Underlying: Common Stock · 30,700 shares Expires 2035-06-13 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:05 UTC |
Manning Anthony M.Director
|
GrantStock Option (Right to Buy) · Derivative | 30,700 | $0.00 Strike: $4.91 | $0.00 |
DisclosureSEC source: 0000950170-25-086703 · ownership.xml · derivative · entry 1 Manning Anthony M. · CIK 0001716468 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,700 Underlying: Common Stock · 30,700 shares Expires 2035-06-13 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 16:05 UTC |
Siu ChristineDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,700 | $0.00 Strike: $4.91 | $0.00 |
DisclosureSEC source: 0000950170-25-086701 · ownership.xml · derivative · entry 1 Siu Christine · CIK 0001743029 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,700 Underlying: Common Stock · 30,700 shares Expires 2035-06-13 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:05 UTC |
Skvarka JanDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,700 | $0.00 Strike: $4.91 | $0.00 |
DisclosureSEC source: 0000950170-25-086700 · ownership.xml · derivative · entry 1 Skvarka Jan · CIK 0001838042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,700 Underlying: Common Stock · 30,700 shares Expires 2035-06-13 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.